Tracking biomarkers across these systems enables better care 85%+ Muscle mass preserved With guidance, patients preserve lean muscle through targeted protein and strength protocols Most GLP-1 programs fall short Without clinical support Higher risk of losing lean tissue Muscle loss Derail treatment adherence Side effects Weight loss without metabolic health No metabolic tracking Most quit within 6 months Early discontinuation Multi-system intervention Success measured across the body Clinician-led care with ongoing oversight Dosing, tolerance, and response actively managed Decisions guided by biological feedback Biomarkers and symptoms used to protect long-term health Long-term healthspan Designed to support aging, resilience, and metabolic health Clinician-guided GLP-1 treatment Your clinician reviews your medical history and goals to determine eligibility and guide the right treatment choice, including injectable or oral options
Joint pain developing after starting B12 may reflect: Pre-existing musculoskeletal conditions becoming more noticeable Concurrent inflammatory or degenerative joint disease Reactions to excipients in certain formulations The natural course of an underlying condition If you experience persistent or worsening joint symptoms after beginning B12 supplementation, it is advisable to consult your GP or healthcare provider
American Medical Association: What Doctors Wish Patients Knew About Anti-Obesity Medication Centers for Disease Control and Prevention: Steps for Losing Weight Harvard Health Publishing: GLP-1 Diabetes and Weight-Loss Drug Side Effects: Ozempic Face and More Keck Medicine of USC: What Doctors Think About Prescribing Wegovy and Ozempic for Weight Loss Rodriguez PJ et al
Video games have enthusiastically mined the oeuvre of gothic author HP Lovecraft, but The Sinking City might just be the most Lovecraftian game yet
Jensen says he prefers patients speak to their doctors before turning to med spas or online clinics, especially as demand continues to climb
